Abstract
Calcium pyrophosphate deposition (CPPD) can be induced by a persistent hypomagnesemia. Tacrolimus is an immunosuppressive treatment especially used in organ transplant, potentially inducer of hypomagnesemia by renal loss. A 53-year-old man, liver transplant 10 months earlier, developed an acute peripheral oligoarthritis of wrist, hip and elbow with fever, associated with acute low back pain. Synovial fluid was sterile, and revealed calcium pyrophosphate crystals. Spinal imaging showed inflammatory changes. Magnesium blood level was low at 0.51 mmol/l, with high fractional excretion in favor of renal loss. Tacrolimus was changed for everolimus, proton pump inhibitor was stopped, and magnesium oral supplementation was started. After 8 months follow-up and slow prednisone tapering, he did not relapse pain. Persistent hypomagnesemia is a rare secondary cause of CPPD. In this entity, drug liability should be investigated such as tacrolimus in organ transplant patient.
Similar content being viewed by others
References
Rosenthal AK, Ryan LM (2016) Calcium pyrophosphate deposition disease. N Engl J Med 374:2575–2584. https://doi.org/10.1056/NEJMra1511117
Moshrif A, Laredo JD, Bassiouni H et al (2019) Spinal involvement with calcium pyrophosphate deposition disease in an academic rheumatology center: a series of 37 patients. Semin Arthritis Rheum 48:1113–1126. https://doi.org/10.1016/j.semarthrit.2018.10.009
Grobost V, Vayssade M, Roche A et al (2014) Axial calcium pyrophosphate dihydrate deposition disease revealed by recurrent sterile spondylodiscitis and epidural abscess. Joint Bone Spine 81:180–182. https://doi.org/10.1016/j.jbspin.2013.07.007
Jones AC, Chuck AJ, Arie EA et al (1992) Diseases associated with calcium pyrophosphate deposition disease. Semin Arthritis Rheum 22:188–202. https://doi.org/10.1016/0049-0172(92)90019-a
Ea H-K, Blanchard A, Dougados M, Roux C (2005) Chondrocalcinosis secondary to hypomagnesemia in Gitelman’s syndrome. J Rheumatol 32:1840–1842
Cipolletta E, Di Matteo A, Filippucci E, Grassi W (2019) Calcium pyrophosphate deposition disease in a patient with familial hypokalemia-hypomagnesemia (Gitelman’s-Syndrome): a case report. Ultraschall Med. https://doi.org/10.1055/a-0990-9960
Richette P, Ayoub G, Bardin T et al (2005) Hypomagnesemia and chondrocalcinosis in short bowel syndrome. J Rheumatol 32:2434–2436
Nijenhuis T, Hoenderop JGJ, Bindels RJM (2004) Downregulation of Ca(2+) and Mg(2+) transport proteins in the kidney explains tacrolimus (FK506)-induced hypercalciuria and hypomagnesemia. J Am Soc Nephrol 15:549–557. https://doi.org/10.1097/01.asn.0000113318.56023.b6
Favero M, Calò LA, Schiavon F, Punzi L (2011) Miscellaneous non-inflammatory musculoskeletal conditions. Bartter’s and Gitelman’s diseases. Best Pract Res Clin Rheumatol 25:637–648. https://doi.org/10.1016/j.berh.2011.10.013
Guerne P-A (2010) Chondrocalcinosis and calcium pyrophosphate (CPP) crystal deposition disease in 2010. Revue Medicale Suisse 6:555–556
Cheungpasitporn W, Thongprayoon C, Kittanamongkolchai W et al (2015) Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies. Ren Fail 37:1237–1241. https://doi.org/10.3109/0886022X.2015.1057800
Perez-Ruiz F, Testillano M, Gastaca MA, Herrero-Beites AM (2001) “Pseudoseptic” pseudogout associated with hypomagnesemia in liver transplant patients. Transplantation 71:696–698. https://doi.org/10.1097/00007890-200103150-00022
Diep JT, Kerr LD, Barton C, Emre S (2008) Musculoskeletal manifestations in liver transplantation recipients. J Clin Rheumatol Pract Rep Rheum Musculoskel Dis 14:257–260. https://doi.org/10.1097/RHU.0b013e3181870212
Cenin DA, Freyer CW, Ligon CB et al (2020) Tacrolimus induced pseudogout following allogeneic hematopoietic cell transplant. J Oncol Pharm Pract. https://doi.org/10.1177/1078155220951241
Martinon F, Pétrilli V, Mayor A et al (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237–241. https://doi.org/10.1038/nature04516
Mariathasan S, Newton K, Monack DM et al (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430:213–218. https://doi.org/10.1038/nature02664
Jahnen-Dechent W, Ketteler M (2012) Magnesium basics. Clin Kidney J 5:i3–i14. https://doi.org/10.1093/ndtplus/sfr163
Srinutta T, Chewcharat A, Takkavatakarn K et al (2019) Proton pump inhibitors and hypomagnesemia: a meta-analysis of observational studies. Med (Baltim) 98:e17788. https://doi.org/10.1097/MD.0000000000017788
Sivakumar J (2016) Proton pump inhibitor-induced hypomagnesaemia and hypocalcaemia: case review. Int J Physiol Pathophysiol Pharmacol 8:169–174
Kleiber Balderrama C, Rosenthal AK, Lans D et al (2017) Calcium pyrophosphate deposition disease and associated medical comorbidities: a national cross-sectional study of US veterans. Arthritis Care Res (Hoboken) 69:1400–1406. https://doi.org/10.1002/acr.23160
Amanova A, Kendi Celebi Z, Bakar F et al (2014) Colchicine levels in chronic kidney diseases and kidney transplant recipients using tacrolimus. Clin Transplant 28:1177–1183. https://doi.org/10.1111/ctr.12448
Yousuf Bhat Z, Reddy S, Pillai U et al (2016) Colchicine-induced myopathy in a tacrolimus-treated renal transplant recipient: case report and literature review. Am J Ther 23:e614-616. https://doi.org/10.1097/MJT.0000000000000044
Nguyen LS, Vautier M, Allenbach Y et al (2019) Sirolimus and mTOR inhibitors: a review of side effects and specific management in solid organ transplantation. Drug Saf 42:813–825. https://doi.org/10.1007/s40264-019-00810-9
Kolaitis NA, Calabrese DR, Ahearn P et al (2019) Tacrolimus trough monitoring guided by mass spectrometry without accounting for assay differences is associated with acute kidney injury in lung transplant recipients. Am J Health Syst Pharm 76:2019–2027. https://doi.org/10.1093/ajhp/zxz243
Zhang W, Doherty M, Pascual E et al (2011) EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis 70:571–575. https://doi.org/10.1136/ard.2010.139360
Alvarellos A, Spilberg I (1986) Colchicine prophylaxis in pseudogout. J Rheumatol 13:804–805
Grotz WH, Breitenfeldt MK, Braune SW et al (2001) Calcineurin-inhibitor induced pain syndrome (CIPS): a severe disabling complication after organ transplantation. Transpl Int 14:16–23. https://doi.org/10.1007/s001470000285
Rozenberg S, Bourgeois P (1995) Osteo-articular complications of heart transplantation. Presse Med 24:1809–1812
Udomkarnjananun S, Townamchai N, Virojanawat M et al (2018) An unusual manifestation of calcineurin inhibitor-induced pain syndrome in kidney transplantation: a case report and literature review. Am J Case Rep 19:442–446. https://doi.org/10.12659/ajcr.908886
Lee RS, Kayser MV, Ali SY (2006) Calcium phosphate microcrystal deposition in the human intervertebral disc. J Anat 208:13–19. https://doi.org/10.1111/j.1469-7580.2006.00504.x
Author information
Authors and Affiliations
Contributions
SC, for conception and design, acquisition and interpretation of data and drafting of manuscript. ALG, for case management and revising critically the manuscript. BG, for acquisition of data and revising critically the manuscript. FR, for design and drafting of systematic literature review and revising critically the manuscript. MM, for case management and revising critically the manuscript. XG, for conception and revising critically the manuscript. GP, for conception and design, drafting and revising critically the manuscript. MSR, for case management, conception and design, acquisition of data and revising the manuscript. All the authors approve this final version and agree to be accountable for all aspects of the work if questions arise related to its accuracy or integrity.
Corresponding author
Ethics declarations
Conflict of interest
None of the authors have conflict of interest to declare for this article.
Informed consent
Patient gave consent to participate and for publishing.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cadiou, S., Le Gruyer, A., Giguet, B. et al. Calcium pyrophosphate deposition (CPPD) in a liver transplant patient: are hypomagnesemia, tacrolimus or both guilty? A case-based literature review. Rheumatol Int 42, 1105–1112 (2022). https://doi.org/10.1007/s00296-021-04828-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-021-04828-0